Literature DB >> 12948745

Cellular distribution of phosphofructokinase activity and implications to metabolic regulation in human breast cancer.

Tatiana El-Bacha1, Marta Sampaio de Freitas, Mauro Sola-Penna.   

Abstract

Neoplastic cells generally present profound changes in glucose metabolism. The mechanisms underlying such process are numerous and all may involve altered cellular hormonal responses. Here we report the first evidence that cellular location of phosphofructokinase activity in human breast cancer tissues is different from the one observed in control tissues and that this phenomenon may be involved in the increased glycolytic flux observed in those cells. Through co-sedimentation techniques, we observed that 60% of phosphofructokinase activity in neoplastic tissues is located in an actin-enriched fraction, against 36% in control tissues. Additionally, metastatic tumor tissues presented a two fold increase in this particulate activity when compared to non-metastatic tumor samples. We propose that the alteration in cellular distribution of phosphofructokinase activity in human breast cancer tissues is a mechanism associated to the process of cell transformation and may be a consequence of the altered hormonal milieu observed in several types of cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948745     DOI: 10.1016/s1096-7192(03)00117-3

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  13 in total

1.  Mayaro virus infection alters glucose metabolism in cultured cells through activation of the enzyme 6-phosphofructo 1-kinase.

Authors:  Tatiana El-Bacha; Maíra M T Menezes; Melissa C Azevedo e Silva; Mauro Sola-Penna; Andrea T Da Poian
Journal:  Mol Cell Biochem       Date:  2004-11       Impact factor: 3.396

2.  Serotonin regulates 6-phosphofructo-1-kinase activity in a PLC-PKC-CaMK II- and Janus kinase-dependent signaling pathway.

Authors:  Wagner Santos Coelho; Mauro Sola-Penna
Journal:  Mol Cell Biochem       Date:  2012-09-26       Impact factor: 3.396

3.  Shikonin, vitamin K3 and vitamin K5 inhibit multiple glycolytic enzymes in MCF-7 cells.

Authors:  Jing Chen; Xun Hu; Jingjie Cui
Journal:  Oncol Lett       Date:  2018-03-13       Impact factor: 2.967

4.  Lactate favours the dissociation of skeletal muscle 6-phosphofructo-1-kinase tetramers down-regulating the enzyme and muscle glycolysis.

Authors:  Tiago Costa Leite; Daniel Da Silva; Raquel Guimarães Coelho; Patricia Zancan; Mauro Sola-Penna
Journal:  Biochem J       Date:  2007-11-15       Impact factor: 3.857

5.  Investigation of glucose catabolism in hypoxic Mcf 7 breast cancer culture.

Authors:  İrem Bayar; Ayşegül Bildik
Journal:  Cytotechnology       Date:  2021-02-20       Impact factor: 2.058

6.  RNAi-mediated knockdown of PFK1 decreases the invasive capability and metastasis of nasopharyngeal carcinoma cell line, CNE-2.

Authors:  Shuo Li; Peng He; Zhiwei Wang; Meng Liang; Wei Liao; Yili Huang; Mengshi Chi; Fei Liu; Nan Zen; Rongfei Su; Shulin Chen; Zhigang Liu; Haiyu Hong
Journal:  Cell Cycle       Date:  2021-01-06       Impact factor: 4.534

7.  Clotrimazole preferentially inhibits human breast cancer cell proliferation, viability and glycolysis.

Authors:  Cristiane M Furtado; Mariah C Marcondes; Mauro Sola-Penna; Maisa L S de Souza; Patricia Zancan
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

8.  Differential phosphofructokinase-1 isoenzyme patterns associated with glycolytic efficiency in human breast cancer and paracancer tissues.

Authors:  Guannan Wang; Zhiliang Xu; Changhua Wang; Feng Yao; Juanjuan Li; Chuang Chen; Shengrong Sun
Journal:  Oncol Lett       Date:  2013-10-01       Impact factor: 2.967

9.  Hexokinase and phosphofructokinase activity and intracellular distribution correlate with aggressiveness and invasiveness of human breast carcinoma.

Authors:  Raquel G Coelho; Isadora C Calaça; Deborah M Celestrini; Ana Helena P Correia-Carneiro; Mauricio M Costa; Patricia Zancan; Mauro Sola-Penna
Journal:  Oncotarget       Date:  2015-10-06

10.  Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells.

Authors:  Annapoorna Sreedhar; Yunfeng Zhao
Journal:  Biomed Rep       Date:  2017-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.